Loading...
0

Global Autoimmune Disease Therapeutics Market Expected to Reach $153,320 Million by 2025

 
 

quote Recent launch of advanced therapeutics plays a major role in the growth of the autoimmune disease therapeutics market. Furthermore, increase in prevalence of autoimmune disease and strong presence of late stage pipeline drugs are expected to boost the market growth in the coming years. quote

Onkar Sumant
Assistant Manager, Healthcare Research at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.

Autoimmune disease therapeutics include different types of drugs such as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, immune suppressants, corticosteroids, beta-blockers, and others. The demand for autoimmune disease therapeutics is estimated to increase during the forecast period owing to surge in prevalence of autoimmune disease, advancement in screening & diagnosis procedures, and wide availability of advanced therapeutics. Moreover, strong presence of pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others is expected to further boost the market growth.

Based on drug class, the global autoimmune disease therapeutics market is segmented into anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. Anti-inflammatory was the major revenue contributing segment in 2017, and is expected to maintain its dominance during the forecast period owing to increase in demand for anti- inflammatory drugs, launch of newer anti- inflammatory drugs with the supportive reimbursement policies for usage of advanced anti- inflammatory drugs in some countries. Moreover, expected launch of pipeline anti-inflammatories such as tocilizumab, certolizumab, secukinumab, etanercept, golimumab, and others, is estimated to further influence the market growth.

Based on indication, the market is classified as rheumatic disease, type 1 diabetes, multiple sclerosis, inflammatory bowel disease, and other indications. Rheumatic disease segment accounted for a major share in 2017 and is expected to remain dominant during the forecast period owing to surge in prevalence of arthritis, fibromyalgia, systemic lupus erythematosus, gout, scleroderma, polymyalgia rheumatica and others, wide availability of advanced therapeutics for treatment of rheumatic disease, availability of advanced therapeutics for the treatment of these diseases.

According to sales channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online stores. Online providers segment is expected to experience rapid growth during the forecast period owing to rise in preference for online purchasing of drugs over the traditional methods and increase in awareness about online pharmacy with rise in number of internet users. On the other side, drug store & retail pharmacy segment is estimated to be the major revenue contributor due to massive presence of these pharmacies.

Key Findings of theAutoimmune Disease Therapeutics Market:

  • Based on indication, the rheumatic disease segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025.
  • Based on sales channel, the online stores segment is expected to experience rapid growth and is projected to grow at a CAGR of 6.8% during the forecast period 2018-2025.
  • Depending on drug class, the anti-inflammatory segment accounted for nearly half of the global market share in 2017, and is projected to grow at a CAGR of 5.2% from 2018 to 2025.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.3% during the forecast period.

North America accounted for a major market share in 2017, and is expected to remain dominant throughout the forecast period. Higher prevalence of autoimmune disease, early diagnosis, easy availability of advanced therapeutics, strong presence of key players, favorable reimbursement in healthcare system, and higher number of trained medical professionals are key drivers of the North America autoimmune disease therapeutics market. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period owing to increase in number of target population, rise in adoption of therapeutics with development in healthcare infrastructure.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Shaun Godinho
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Autoimmune Disease Therapeutics Market by Drug Class (Anti-Inflammatory, Antihyperglycemics, NSAIDs, Interferons, and Others), Indication (Rheumatic Disease, Type 1 Diabetes, Multiple Sclerosis, , Inflammatory Bowel Disease and Others) and Sales Channel (Hospital Pharmacy, Drug Store & Retail Pharmacy, and Online Store): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 quote

View Report
 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Global Autoimmune Disease Therapeutics Market"
Purchase Enquiry